Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review. Avedillo-Salas A, Martínez L B, Fanlo-Villacampa A, Vicente-Romero J J Neurol. 2026 Apr 22; 273(5). PMID: 42018029. Abstract CommentRecommendBookmarkWatch